Thursday, September 21, 2023

GA_P, RocaJunyent advise on Labiana’s IPO on BME Growth

Gómez-Acebo & Pombo has advised the issuer while RocaJunyent has counselled the underwriters


The animal and human health platform Labiana is finalising its IPO for mid-June through a capital increase, with the aim of “accelerating growth and improving market positioning through a defined plan of organic and inorganic growth”.

In a statement, Labiana said it has already met with “reference” investors, both in Spain and Europe, and has secured the commitment of the venture capital firm Inveready, which will invest up to four million euros.

Founded in 1958, the company specialises in the manufacture of pharmacological products for veterinary use and has a portfolio of its own medicines with more than fifty products marketed in more than 150 countries and with more than three hundred customers.

The group is now looking to continue to grow “benefiting from positive market trends, growth in the contract development and manufacturing (CDMO) segment, the launch of new proprietary products in both animal and human health and the entry into new markets, as well as improving its profitability through operational leverage and manufacturing process efficiencies, as a result of all the investments made in the production facilities”.

“We are very pleased with the work that has been done since 2013 when the management team took this step forward to take over the group. The IPO represents the result of this first stage and the beginning of a new one,” said the company’s CEO, Manuel Ramos Ortega.

RocaJuntent has advised underwriters JVC Capital, Caixabank, and Gaesco, with a team led by partner Jaime Tarrero, while Gómez-Acebo & Pombo has advised the issuer.

Gómez-Acebo & Pombo team was led by partner Augusto Piñel, along with senior associate Jacobo Palanca Reh, and associates Emiliano Moreno Rodríguez e Irene Carreño Uría.

- Advertisement -spot_img
- Advertisement -spot_img


Ecija guides Revel’s 115m financing round

The round, which consists of a €15 million equity investment and a €100 million structured financing, will allow them to accelerate our growth in...

Uría Menéndez advises DFDS on acquisition of FRS Iberia/Maroc

The international ferry company FRS, based in Flensburg, is disassociating itself from the subsidiary FRS Iberia/Maroc. In the future, the ferry lines between Spain...

Andersen creates new European management committee, adds Morete as its member

With this new appointment of José Vicente, our Iberia office takes on a key position to contribute to the short, medium and long-term success...
- Advertisement -spot_img